RecruitingNCT06693180
Registry HBOT in DFU
Registry Hyperbaric Oxygen in Diabetic Foot Ulcer
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Enrollment
600 participants
Start Date
Nov 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Overview of available data to assess the benefits of HBOT to DFU patients
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Diabetes mellitus
- Meggitt-Wagner classification grade 2-4, existing > 4 weeks
- Complete 1 year follow-up
Exclusion Criteria8
- Chronic Obstructive Pulmonary Disease (COPD) GOLD IV
- Treatment with chemotherapy, immunosuppressive drugs or systemic corticosteroids within the last 3 months
- Metastasized malignancy
- Left ventricular ejection fraction (EF) <20% or external pacemaker
- Recent thoracic or middle ear surgery
- Severe epilepsy
- Uncontrollable high fever
- Pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERHBOT
Hyperbaric Oxygen Therapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06693180